Open House Biologika Rabattverträge 2026-24 - Aflibercept (ATC: S01LA05; Wirkstärke: 40 mg/ml)
openRead the notice at vergabe-de ↗
Value
unstated
Published
17 Nov 2026
Deadline
31 Dec 2026, 22:58 GMT · 40d left · as published, verify on the notice
Type
opportunity
33600000 · Medical equipment, pharmaceuticals & personal careDE600
Description
Die TK verfolgt das Ziel, mit allen geeigneten pharmazeutischen Unternehmern Rabattverträge nach § 130a Abs. 8 SGB V zu dem Wirkstoff Aflibercept (ATC: S01LA05; Wirkstärke: 40 mg/ml) zu schließen.
Key facts
- Reference
- OH-Biologika-2026-24
- Procedure
- open
- Lots
- 1
- Contact
- DZEM@tk.de+49 4069094-040
- Bids opened
- 31 Dec 2026, 22:59 GMT
- Regime
- publicSector
What a subscription adds to this notice
- The documents — every attachment, with its text extracted and searchable
- Qualification — the notice scored against your company profile
- Tracking and alerts — a pipeline for your bids, and the matching notices by email
- Calendar export — the deadline as a calendar file
- The API and MCP — the same record in your own tools and your AI assistant
Provenance
- Source
- vergabe-de
- Notice id
- c0fdd64e-c55a-41af-ae79-f9f9207cae85
- OCID
- ocds-mnwr74-70109477-82db-4403-b21a-4a5481722f56
- First seen
- 22 Nov 2026
- Last updated
- 22 Nov 2026
Licence CC0 1.0 public domain dedication ↗
Source: Bekanntmachungsservice (oeffentlichevergabe.de), Beschaffungsamt des BMI — CC0 1.0.
View at source ↗
GET /api/v1/tenders/0e34459c-1c97-487a-9b11-540354e17142The source notice is authoritative — verify deadlines and documents there before bidding.